- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Payers Review Process and Effective Strategies for PDT Coverage
Paul Jeffrey, PharmD, presents the findings of a study, which investigated patient engagement and clinical outcomes associated with the use of prescription digital therapeutics (PDTs) in the treatment of substance use disorders, and discusses the need for further research to advance the efficacy and value of PDTs in this field.
EP: 1.Differentiating PDTs from Wellness Apps and Evaluating Efficacy
EP: 2.Payer Needs and Strategies for Evaluating and Covering PDTs
EP: 3.Payers Review Process and Effective Strategies for PDT Coverage
EP: 4.Stakeholder Involvement and Evidence Requirements for PDT Coverage Decisions
EP: 5.Dawn of the Age of Adopting PDTs
EP: 6.Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
EP: 7.Evolving Commercialization and Distribution Models for PDTs
EP: 8.Promoting Appropriate PDT Prescribing Through Provider Education and Support
EP: 9.Optimizing Provider Education, Utilization Monitoring, and Value-Based Contracts for PDTs
EP: 10.Optimizing Benefit Design and Implementation for Improved PDT Access
EP: 11.PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
Ovarian Cancer Outcomes Linked to Preoperative Immunonutritional Status
February 18th 2025In patients with early-stage ovarian cancer, a high prognostic nutritional index improved survival, while a high systemic immune-inflammation index worsened it. In advanced stages, both affected overall survival but not progression-free survival.
Read More
